VSee Health, Inc. VSEED
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.92% | 5.13% | 18.67% | 98.07% | -26.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.92% | 5.13% | 18.67% | 98.07% | -26.12% |
| Cost of Revenue | 197.34% | 54.57% | 234.81% | 92.77% | 0.28% |
| Gross Profit | -10.22% | -22.97% | -25.55% | 104.44% | -34.38% |
| SG&A Expenses | 1.26% | -0.99% | 4.61% | 122.16% | 113.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.93% | 10.27% | 33.64% | 133.67% | 84.13% |
| Operating Income | -7.27% | -16.78% | -76.76% | -220.18% | -1,286.43% |
| Income Before Tax | 65.78% | -145.17% | 99.46% | -11.27% | -3,924.47% |
| Income Tax Expenses | 71.85% | 88.76% | -- | 100.27% | -- |
| Earnings from Continuing Operations | 65.27% | -144.71% | 99.46% | -292.33% | -3,938.71% |
| Earnings from Discontinued Operations | -317.27% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.33% | -144.71% | 99.46% | -312.13% | -6,404.78% |
| EBIT | -7.27% | -16.78% | -76.76% | -220.18% | -1,286.43% |
| EBITDA | -12.54% | -22.87% | -174.26% | -128.70% | -787.02% |
| EPS Basic | 78.09% | -23.57% | 99.51% | -33.06% | -1,893.99% |
| Normalized Basic EPS | 85.20% | -26.24% | -106.83% | 61.18% | -1,574.73% |
| EPS Diluted | 78.09% | -23.57% | 99.51% | -33.06% | -2,527.04% |
| Normalized Diluted EPS | 85.20% | -26.24% | -106.83% | 61.18% | -1,574.73% |
| Average Basic Shares Outstanding | 199.80% | 98.03% | 9.76% | 209.65% | 251.55% |
| Average Diluted Shares Outstanding | 199.80% | 98.03% | 9.76% | 209.65% | 251.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |